
Kamal A. Saeed
Examiner (ID: 510)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626 |
| Total Applications | 3118 |
| Issued Applications | 2323 |
| Pending Applications | 319 |
| Abandoned Applications | 524 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5485992
[patent_doc_number] => 20090275757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'NOVEL CRYSTAL OF 3-[5-[4-(CYCLOPENTYLOXY)-2- HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BENZISOXAZOL-6- YL)METHOXY]PHENYL]PROPIONIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/302375
[patent_app_country] => US
[patent_app_date] => 2007-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4917
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275757.pdf
[firstpage_image] =>[orig_patent_app_number] => 12302375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/302375 | Crystal of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid | May 24, 2007 | Issued |
Array
(
[id] => 4772743
[patent_doc_number] => 20080058402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Substituted Thieno[2,3-c]pyrazoles, Process for Preparing Them, Compositions Containing Them, and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/752612
[patent_app_country] => US
[patent_app_date] => 2007-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13560
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20080058402.pdf
[firstpage_image] =>[orig_patent_app_number] => 11752612
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/752612 | Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof | May 22, 2007 | Issued |
Array
(
[id] => 4443013
[patent_doc_number] => 07928266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-19
[patent_title] => 'Dialdehyde compound, preparation method thereof, and synthetic method of carotenoids using the same'
[patent_app_type] => utility
[patent_app_number] => 12/308028
[patent_app_country] => US
[patent_app_date] => 2007-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10186
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/928/07928266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12308028
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308028 | Dialdehyde compound, preparation method thereof, and synthetic method of carotenoids using the same | May 22, 2007 | Issued |
Array
(
[id] => 5126464
[patent_doc_number] => 20070238735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Cyclooxygenase-2 selective inhibitors, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/802161
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33426
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238735.pdf
[firstpage_image] =>[orig_patent_app_number] => 11802161
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/802161 | Cyclooxygenase-2 selective inhibitors, compositions and methods of use | May 20, 2007 | Abandoned |
Array
(
[id] => 8082203
[patent_doc_number] => 08148418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'
[patent_app_type] => utility
[patent_app_number] => 12/301180
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 49071
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148418.pdf
[firstpage_image] =>[orig_patent_app_number] => 12301180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301180 | Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | May 16, 2007 | Issued |
Array
(
[id] => 8082211
[patent_doc_number] => 08148417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'
[patent_app_type] => utility
[patent_app_number] => 12/301172
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 84679
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12301172
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301172 | Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | May 16, 2007 | Issued |
Array
(
[id] => 7997643
[patent_doc_number] => 08080669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-20
[patent_title] => 'Process for the synthesis of 2-aminoxazole compounds'
[patent_app_type] => utility
[patent_app_number] => 12/299901
[patent_app_country] => US
[patent_app_date] => 2007-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3615
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/080/08080669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12299901
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/299901 | Process for the synthesis of 2-aminoxazole compounds | May 10, 2007 | Issued |
Array
(
[id] => 5126483
[patent_doc_number] => 20070238754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Novel CB 1 receptor inverse agonists'
[patent_app_type] => utility
[patent_app_number] => 11/801727
[patent_app_country] => US
[patent_app_date] => 2007-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32615
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11801727
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/801727 | CB 1 receptor inverse agonists | May 9, 2007 | Issued |
Array
(
[id] => 5259755
[patent_doc_number] => 20070213387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Substituted pyrrolines as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/800912
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23203
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213387.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800912 | Substituted pyrrolines as kinase inhibitors | May 7, 2007 | Issued |
Array
(
[id] => 64124
[patent_doc_number] => 07759380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'Substituted pyrrolines as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/800878
[patent_app_country] => US
[patent_app_date] => 2007-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23333
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/759/07759380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11800878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/800878 | Substituted pyrrolines as kinase inhibitors | May 7, 2007 | Issued |
Array
(
[id] => 7533221
[patent_doc_number] => RE042889
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2011-11-01
[patent_title] => 'α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors'
[patent_app_type] => reissue
[patent_app_number] => 11/788947
[patent_app_country] => US
[patent_app_date] => 2007-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40373
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/042/RE042889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11788947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/788947 | α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors | Apr 22, 2007 | Issued |
Array
(
[id] => 4906476
[patent_doc_number] => 20080017242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'GROUP IV NANOPARTICLES IN AN OXIDE MATRIX AND DEVICES MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 11/738221
[patent_app_country] => US
[patent_app_date] => 2007-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3802
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20080017242.pdf
[firstpage_image] =>[orig_patent_app_number] => 11738221
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/738221 | Group IV nanoparticles in an oxide matrix and devices made therefrom | Apr 19, 2007 | Issued |
Array
(
[id] => 8082441
[patent_doc_number] => 08148536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Comestible compositions comprising high potency savory flavorants, and processes for producing them'
[patent_app_type] => utility
[patent_app_number] => 12/297986
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43574
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12297986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/297986 | Comestible compositions comprising high potency savory flavorants, and processes for producing them | Apr 18, 2007 | Issued |
Array
(
[id] => 8177375
[patent_doc_number] => 08178573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/226372
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27890
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12226372
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/226372 | Compounds | Apr 17, 2007 | Issued |
Array
(
[id] => 369896
[patent_doc_number] => 07476669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-13
[patent_title] => 'Cytotoxic agents comprising taxanes and their therapeutic use'
[patent_app_type] => utility
[patent_app_number] => 11/785482
[patent_app_country] => US
[patent_app_date] => 2007-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9539
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/476/07476669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11785482
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/785482 | Cytotoxic agents comprising taxanes and their therapeutic use | Apr 17, 2007 | Issued |
Array
(
[id] => 5011467
[patent_doc_number] => 20070281946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'TRI(CYCLO) SUBSTITUTED AMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/735685
[patent_app_country] => US
[patent_app_date] => 2007-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27040
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281946.pdf
[firstpage_image] =>[orig_patent_app_number] => 11735685
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/735685 | Tri(cyclo) substituted amide compounds | Apr 15, 2007 | Issued |
Array
(
[id] => 4568018
[patent_doc_number] => 07847104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors'
[patent_app_type] => utility
[patent_app_number] => 11/734900
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8872
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/847/07847104.pdf
[firstpage_image] =>[orig_patent_app_number] => 11734900
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/734900 | Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptors | Apr 12, 2007 | Issued |
Array
(
[id] => 5113501
[patent_doc_number] => 20070197417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Organic catalyst with enhanced enzyme compatiblity'
[patent_app_type] => utility
[patent_app_number] => 11/786653
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8849
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786653 | Organic catalyst with enhanced enzyme compatiblity | Apr 11, 2007 | Abandoned |
Array
(
[id] => 5113505
[patent_doc_number] => 20070197421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Organic catalyst with enhanced enzyme compatibility'
[patent_app_type] => utility
[patent_app_number] => 11/786654
[patent_app_country] => US
[patent_app_date] => 2007-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8891
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197421.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786654
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786654 | Organic catalyst with enhanced enzyme compatibility | Apr 11, 2007 | Abandoned |
Array
(
[id] => 6257700
[patent_doc_number] => 20100029700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => '1-(2-ARYL-2-OXOETHYL)-3-PHENYL-1, 4-DIAZASPIRO [4.5]DEC-3-EN-2-ONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/296712
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18504
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029700.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296712
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296712 | 1-(2-ARYL-2-OXOETHYL)-3-PHENYL-1, 4-DIAZASPIRO [4.5]DEC-3-EN-2-ONE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORTER INHIBITORS | Apr 9, 2007 | Abandoned |